Handelsbanken Fonder Ab Heron Therapeutics, Inc. Transaction History

Handelsbanken Fonder Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$2.3 - $6.29 $64,399 - $176,120	-28,000 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$13.27 - $18.48 $83,601 - $116,424	6,300 Added 29.03%	28,000 $435,000
Q1 2021 Apr 29, 2021	BUY	$14.49 - $20.72 $126,063 - $180,264	8,700 Added 66.92%	21,700 $352,000
Q2 2020 Aug 13, 2020	BUY	$10.89 - $21.47 $141,570 - $279,110	13,000 New	13,000 $191,000

176

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $194M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.